Skip to main content
. 2019 Dec 30;15(4):397–415. doi: 10.1016/j.ajps.2019.11.004

Fig. 2.

Fig 2

Manufacture of RBC(M(TPC-PTX)), brief mechanism in cancer therapy, pharmacokinetics performance, and inhibition of tumor growth. (A) Fabrication of RBC membrane-camouflaged nanoparticles for synergistic photodynamic/chemotherapy. (B) Pharmacokinetics data of PTX2-TK in RBC(M(TCP-PTX)) and M(TCP-PTX) groups. (C) Tumor suppression curve of subcutaneous xenografts in different groups. (A: PBS B: PBS(L+) C: M(PTX) D: M(PTX) (L+) E: M(TPC-PTX) F: M(TPC-PTX) (L+) G: RBC(M(TPC-PTX)) H: RBC(M(TPC-PTX)) (L+)). Reproduced with permission from [60]. Copyright 2018 American Chemical Society.